首页> 外文OA文献 >Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents.

【2h】

Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents.

机译：低分子量肝素与普通肝素对急性ST段抬高型心肌梗死患者进行初次经皮冠状动脉介入治疗并使用药物洗脱支架的情况。

页面导航

著录项
相似文献
相关主题

著录项

作者
Li YJ; Rha SW; Chen KY; Poddar KL; Jin Z; Minami Y; Wang L; Dang Q; Li GP; Ramasamy S; Park JY; Choi CU; Kim JW; Kim EJ; Park CG; Seo HS; Oh DJ; Jeong MH; Ahn YK; Hong TJ; Park JS; Kim YJ; Hur SH; Seong IW; Chae JK; Cho MC; Bae JH; Choi DH; Jang YS; Chae IH; Kim HS; Kim CJ; Yoon JH; Ahn TH; Tahk SJ; Chung WS; Seung KB; Park SJ;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Low molecular weight heparin versus unfractionated heparin in patients with acute non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention with drug-eluting stents [J] . LiY.-J., RhaS.W., ChenK.-Y., Journal of cardiology . 2012,第1期

机译：急性非ST段抬高型心肌梗死患者接受药物洗脱支架经皮冠状动脉介入治疗的低分子量肝素与普通肝素
2. Low molecular weight heparin versus unfractionated heparin in patients with acute non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention with drug-eluting stents [J] . LiY.-J., RhaS.W., ChenK.-Y., Journal of cardiology . 2012,第1期

机译：低分子量肝素与急性非ST段升高患者联合肝素的肝素与药物洗脱支架进行经皮冠状动脉介入的心肌梗死患者
3. Clinical outcomes of brief versus prolonged unfractionated heparin infusion after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in the drug-eluting stent era: real-world, single-centre experience. [J] . Yoo SY, Shin DH, Lee JY, Acta Cardiologica . 2011,第4期

机译：在药物洗脱支架时代，经皮冠状动脉介入治疗ST段抬高型心肌梗死后，短暂肝素输注与长期普通肝素输注的临床结果：真实世界，单中心经验。
4. Impact of Renal Insufficiency on 30-Day Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention [C] . Sakai K., Tosaka A., Soga Y., World Congress on Heart Disease. . 2013

机译：肾功能不全对初级经皮冠状动脉干预治疗的ST段升高心肌梗死患者30天后的影响
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Heparin Versus Bivalirudin in Acute Myocardial Infarction: Unfractionated Heparin Monotherapy Elevated to Primary Treatment in Contemporary Percutaneous Coronary Intervention [O] . Osmar Antonio Centurión 2016

机译：肝素与比伐卢定在急性心肌梗死中的应用：普通肝素单药治疗在当代经皮冠状动脉介入治疗中被提升为一级治疗
7. Low molecular weight heparin versus unfractionated heparin in patients with acute non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention with drug-eluting stents [O] . Li Yong-Jian, Rha Seung Woon, Chen Kang-Yin, 2012

机译：急性非ST段抬高型心肌梗死患者接受药物洗脱支架经皮冠状动脉介入治疗的低分子量肝素与普通肝素

Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents.

著录项

相似文献

相关主题

期刊订阅